Date | Title | Description | Source |
15.06.2023 | Confo Therapeutics Enters into Research Collaboration for GP... | • Collaboration to make use of Confo’s unique suite of ConfoBody®-enabled antibody discovery technol... | fundplus.b... |
02.03.2023 | Confo Therapeutics Announces Global Licensing Agreement with... | Ghent, Belgium – March 2, 2023 – Confo Therapeutics, a leader in the discovery of medicines targetin... | fundplus.b... |
16.12.2021 | Confo Therapeutics Expands Patent Estate for ConfoBody®-base... | Confo Therapeutics Expands Patent Estate for ConfoBody®-based GPCR Screening Platform
Ghent, Belgiu... | fundplus.b... |
30.11.2021 | Confo Therapeutics Enters Collaborative Agreement with Regen... | Confo Therapeutics Enters Collaborative Agreement with Regeneron
— Confo will work together with Re... | fundplus.b... |
30.11.2021 | Confo Therapeutics Enters Collaborative Agreement with Regen... | Confo will work together with Regeneron to apply its GPCR drug discovery platform to enable function... | wellington... |
30.03.2021 | Confo Therapeutics awarded € 1 million VLAIO grant for pre-c... | Ghent, Belgium: 30 March 2021 – Confo Therapeutics announced today that it has been awarded a € 1 mi... | capricorn.... |
15.10.2020 | Confo Therapeutics announces selection of first product cand... | Ghent, Belgium: 15 October 2020 – Confo Therapeutics today announced the selection of its first prec... | capricorn.... |
10.06.2020 | Confo Therapeutics expands Board with appointment of Rob Sco... | Ghent, Belgium: 10 June 2020 – Confo Therapeutics today announced the addition of a new member to it... | capricorn.... |
03.06.2020 | Confo Therapeutics appoints Paolo Vicini as Chief Developmen... | New management role underscores Company’s commitment to establishing and advancing its proprietary p... | capricorn.... |
27.02.2020 | Confo Therapeutics to present at Cowen 40th Annual Health Ca... | Ghent, Belgium: 27 February 2020 – Confo Therapeutics, a pioneering biopharma company, today announc... | capricorn.... |
02.12.2019 | Confo Therapeutics reports grant of two key patents for Conf... | Ghent, Belgium: 2 December 2019 – Confo Therapeutics, a pioneering biopharma company, today announce... | capricorn.... |
23.09.2019 | FierceBiotech names Confo Therapeutics as one of its “Fierce... | Confo Therapeutics today announces that it has been named by FierceBiotech as one of 2019’s Fierce 1... | wellington... |
23.09.2019 | FierceBiotech names Confo Therapeutics as one of its “Fierce... | Ghent, Belgium: 23 September 2019 – Confo Therapeutics, a pioneering biopharma company, today announ... | capricorn.... |
03.07.2019 | Confo Therapeutics and DyNAbind announce drug discovery coll... | Ghent, Belgium, and Dresden, Germany: 3 July 2019 – Confo Therapeutics, an emerging drug discovery c... | capricorn.... |
21.06.2019 | Confo Therapeutics receives €1.7 million grant from VLAIO to... | Confo Therapeutics today announces that it has been awarded a €1.7 million grant from Flanders Innov... | wellington... |
20.06.2019 | Confo Therapeutics receives €1.7 million grant from VLAIO to... | Ghent, Belgium: 20 June 2019 – Confo Therapeutics, an emerging drug discovery company, today announc... | capricorn.... |
09.05.2019 | Term Sheet — Thursday, May 9 | UBER HYPE
The biggest IPO since Alibaba. The most anticipated Silicon Valley IPO since Facebook. Th... | fortune.co... |
08.05.2019 | Daily funding roundup - May 8th, 2019 | Journey Meditation raised $2.4M; Data Gumbo landed $6M; Pearl closed $11M; HeyJobs secured $12M
Lor... | vator.tv/n... |
08.05.2019 | Confo Therapeutics Raises €30M in Series A Financing | Confo Therapeutics, a Ghent, Belgium-based drug discovery company, completed a €30m ($33.4m) Series ... | finsmes.co... |
07.05.2019 | Confo Therapeutics raises € 30 million in Series A financing... | Ghent, Belgium: 7 May 2019 – Confo Therapeutics, an emerging drug discovery company, today announces... | capricorn.... |
07.05.2019 | Wellington Partners co-leads €30 million Series A financing ... | Ghent, Belgium, 7 May 2019 – Confo Therapeutics, an emerging drug discovery company, today announces... | wellington... |
07.05.2019 | Confo raises €30M series A round to target hard-to-drug GPCR... | Confo Therapeutics has raised €30 million ($34 million) to take compounds targeting difficult-to-dru... | fiercebiot... |
07.05.2019 | Confo raises €30M series A round to target hard-to-drug GPCR... | Confo Therapeutics has raised €30 million ($34 million) to take compounds targeting difficult-to-dru... | fiercebiot... |
28.02.2019 | Confo Therapeutics forms Scientific Advisory Board as it acc... | Ghent, Belgium: 28 February 2019 – Confo Therapeutics, an emerging drug discovery company, today ann... | capricorn.... |
03.01.2019 | Confo Therapeutics announces exclusive, worldwide license ag... |
Ghent, Belgium: 3 January 2019 – Confo Therapeutics, an emerging drug discovery company, today ann... | capricorn.... |
20.02.2018 | Confo Therapeutics is awarded a € 1 million grant to increas... | Ghent, Belgium: 20 February 2018 – Confo Therapeutics announced today that it has received a € 1 mil... | capricorn.... |
19.12.2017 | Confo Therapeutics enters into drug discovery collaboration ... | Ghent, Belgium: 19 December 2017 – Confo Therapeutics, an emerging drug discovery company, announced... | capricorn.... |
26.09.2017 | Confo Therapeutics enters into drug discovery collaboration ... | Ghent, Belgium: 26 September 2017 – Confo Therapeutics, an emerging drug discovery company, today an... | capricorn.... |
01.02.2017 | Confo Therapeutics is awarded € 2.6 million in non-dilutive ... | Ghent, Belgium: 1 February 2017 – Confo Therapeutics, an emerging drug discovery company, today anno... | capricorn.... |
15.12.2016 | Confo Therapeutics to appoint John Berriman as Chairman of t... | Brussels, Belgium: 15 December 2016 – Confo Therapeutics, an emerging drug discovery company, today ... | capricorn.... |